PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-33.93%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-33.93%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-34.35%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-34.53%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-34.53%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
57.96%
OCF growth under 50% of CRON.TO's 234.45%. Michael Burry might suspect questionable revenue recognition or rising costs.
57.96%
FCF growth 50-75% of CRON.TO's 94.16%. Martin Whitman would see if structural disadvantages exist in generating free cash.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-44.43%
Negative 10Y OCF/share CAGR while CRON.TO stands at 199.63%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-44.43%
Negative 5Y OCF/share CAGR while CRON.TO is at 106.62%. Joel Greenblatt would question the firm’s operational model or cost structure.
-44.43%
Negative 3Y OCF/share CAGR while CRON.TO stands at 115.92%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-265.20%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-265.20%
Negative 5Y net income/share CAGR while CRON.TO is 66.60%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-265.20%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-54.37%
Negative equity/share CAGR over 10 years while CRON.TO stands at 1410.50%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-54.37%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-54.37%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.76%
AR growth well above CRON.TO's 23.99%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
0.79%
Asset growth well under 50% of CRON.TO's 1.85%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-27.60%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
33.93%
SG&A growth well above CRON.TO's 8.16%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.